We demonstrated that gDEC depletes DNMT1 from prostate cancer cells to inhibit their proliferation without activating apoptosis but with epithelial changes that decrease migration and invasion in vitro and in vivo murine xenograft models. This evidence concerns the gene DNMT1 and prostate carcinoma.